Skip to main content
All lobbying filings

SOLUGEN INC

Lobbying for SOLUGEN INC · Industrial Biomanufacturing

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · Texas · House · Senate · $150,000.00 expenses · posted Apr 18, 2025

Official filing document

 Bills named in this filing 1
  • S 4638
    National Defense Authorization Act for Fiscal Year 2025
 Lobbying activity 2
Defense

Support the use of bio-based chemicals in the Department of Defense, generally. (S. 4638) FY 2025 National Defense Authorization Act, educate and advocate for secure supply chains. FY 2026 Defense Appropriations. FY 2026 National Defense Authorization Act.

Environment/Superfund

Educate policymakers about Solugen's technology to produce bio-based chemicals, generally. Monitor implementation of (P.L.117-58), Infrastructure Investment and Jobs Act. Monitor implementation of (P.L. 117-169), Inflation Reduction Act. Monitor implementation of (Executive Order: 14081) Executive Order on Advancing Biotechnology and Biomanufacturing. Educate policymakers on the Premanufacture Notice decision for glucaric acid under (P.L. 114-18) the Frank R. Lautenberg Chemical Safety for the 21st Century Act and on the Environmental Protection Agency's chemical review process.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem